STAT

As the eradication of polio nears, a new crisis for global health looms

The wind-down of the Global Polio Eradication Initiative means the end of the $1 billion a year it funnels into the WHO as well as immunization efforts.
A health worker administers polio vaccines in South Sudan.

The world — or the part that pays attention to polio eradication, anyway — has fixed its sights on zero, the nearly 30-year-old goal of stopping transmission of the paralyzing virus that causes polio. But as the finish line comes into view, officials are largely overlooking a big potential problem, a new report warned Monday.

The wind-down of the Global Polio Eradication Initiative and the roughly $1 billion a year it funnels into the World Health Organization as well as immunization efforts in a number of low-income countries is already underway.

Funding for the initiative is scheduled to be halved by 2019, and to cease after that, except in countries that are still battling polio then or at high risk of seeing the virus return. That will severely deplete the resources and rotavirus, which causes severe and sometimes life-threatening diarrhea.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About A GLP-1 Side Effect, U.K. Clinical Trial Transparency, And More
A new study links GLP-1 drugs like Ozempic to a higher risk of aspiration pneumonia — a lung infection caused by food breathed into the lungs — after endoscopies.
STAT1 min read
STAT+: Medicare Expected To Negotiate Obesity Drug Prices Soon, New Analysis Predicts
Medicare will likely choose the obesity drug semaglutide for price negotiation “within the next few years,” according to a new analysis.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An AstraZeneca Deal, A WHO Pandemic Pact, And More
AstraZeneca agreed to acquire Fusion Pharmaceuticals in a deal worth more than $2 billion, picking up a company focused on targeted radiation therapies for cancer.

Related Books & Audiobooks